[HTML][HTML] Circulating tumour cells for early detection of clinically relevant cancer

R Lawrence, M Watters, CR Davies, K Pantel… - Nature Reviews Clinical …, 2023 - nature.com
Given that cancer mortality is usually a result of late diagnosis, efforts in the field of early
detection are paramount to reducing cancer-related deaths and improving patient outcomes …

COPD and multimorbidity: recognising and addressing a syndemic occurrence

LM Fabbri, BR Celli, A Agustí, GJ Criner… - The Lancet …, 2023 - thelancet.com
Most patients with chronic obstructive pulmonary disease (COPD) have at least one
additional, clinically relevant chronic disease. Those with the most severe airflow obstruction …

[HTML][HTML] Non-coding RNAs in lung cancer: molecular mechanisms and clinical applications

Y Liu, W Ding, J Wang, X Ao, J Xue - Frontiers in oncology, 2023 - ncbi.nlm.nih.gov
Lung cancer (LC) is a heterogeneous disease with high malignant degree, rapid growth,
and early metastasis. The clinical outcomes of LC patients are generally poor due to the …

CCGL-YOLOV5: A cross-modal cross-scale global-local attention YOLOV5 lung tumor detection model

T Zhou, F Liu, X Ye, H Wang, H Lu - Computers in Biology and Medicine, 2023 - Elsevier
Background Multimodal medical image detection is a key technology in medical image
analysis, which plays an important role in tumor diagnosis. There are different sizes lesions …

Prior CT improves deep learning for malignancy risk estimation of screening-detected pulmonary nodules

KV Venkadesh, TA Aleef, ET Scholten, Z Saghir… - Radiology, 2023 - pubs.rsna.org
Background Prior chest CT provides valuable temporal information (eg, changes in nodule
size or appearance) to accurately estimate malignancy risk. Purpose To develop a deep …

[HTML][HTML] Artificial intelligence and lung cancer: impact on improving patient outcomes

Z Gandhi, P Gurram, B Amgai, SP Lekkala… - Cancers, 2023 - mdpi.com
Simple Summary In this comprehensive review, we aimed to summarize the advances made
by artificial intelligence in the field of lung cancer screening, diagnosis, and management …

Low-dose CT screening among never-smokers with or without a family history of lung cancer in Taiwan: a prospective cohort study

GC Chang, CH Chiu, CJ Yu, YC Chang… - The Lancet …, 2024 - thelancet.com
Summary Background In Taiwan, lung cancers occur predominantly in never-smokers, of
whom nearly 60% have stage IV disease at diagnosis. We aimed to assess the efficacy of …

[HTML][HTML] Cancer screening in China: a steep road from evidence to implementation

C Xia, P Basu, BS Kramer, H Li, C Qu, XQ Yu… - The Lancet Public …, 2023 - thelancet.com
Cancer screening has the potential to decrease mortality from several common cancer
types. The first cancer screening programme in China was initiated in 1958 and the Cancer …

Healthy lifestyle and cancer risk: modifiable risk factors to prevent cancer

P Marino, M Mininni, G Deiana, G Marino, R Divella… - Nutrients, 2024 - mdpi.com
Cancer has become a serious problem worldwide, as it represents the main cause of death,
and its incidence has increased over the years. A potential strategy to counter the growing …

Circulating tumor DNA as liquid biopsy in lung cancer: Biological characteristics and clinical integration

C Li, J Shao, P Li, J Feng, J Li, C Wang - Cancer Letters, 2023 - Elsevier
Lung cancer maintains a high morbidity and mortality rate globally despite significant
advancements in detection and therapy in the era of precision medicine. Excisional biopsy …